Related Experiment Video
Updated: Jul 13, 2026
08:03
Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Building, Kansas City, Kansas 66160-7417, USA. cklaasse@kumc.edu
Summary
Transporter proteins significantly influence how the body processes foreign chemicals (xenobiotics). Studies using knockout mice reveal transporter functions crucial for pharmacokinetics and toxicokinetics, aiding in protection against chemical harm.
Area of Science:
- Pharmacology and Toxicology
- Molecular Biology
- Biochemistry
Background:
- Transporter-mediated processes are key to xenobiotic absorption, secretion, and reabsorption.
- Advances in knockout mouse models have significantly enhanced understanding of transporter roles in xenobiotic handling.
Purpose of the Study:
- To review transporter functions in xenobiotics' pharmacokinetics and toxicokinetics, focusing on insights from knockout mice and natural mutations.
- To discuss specific transporter families involved in xenobiotic transport, biliary excretion, and cellular defense mechanisms.
Main Methods:
- Analysis of data from genetically modified (knockout) mice lacking specific transporters.
- Review of studies on humans and rodents with natural mutations in transporter genes.
- Focus on transporters critical for xenobiotic transport across various tissues and cellular barriers.
Main Results:
- Efflux transporters act as barriers, preventing xenobiotic entry, while uptake transporters facilitate entry.
- Transporter function is influenced by substrate specificity, expression levels, and interactions with other transporters.
- Transporters can impact tissues systemically by altering overall xenobiotic metabolism.
Conclusions:
- Understanding transporter roles is vital for predicting xenobiotic biological activities and toxicities.
- Further research into transporter gene regulation and interactions with xenobiotic-metabolizing enzymes is needed.
- This knowledge can inform novel strategies for protecting against xenobiotic insults.
Related Concept Videos
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:31ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:14Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:27Nonlinear Pharmacokinetics: Role of Transporters
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...